3002.14.00.10 - Containing monoclonal antibodies 🖩
Details
| Field | Value |
|---|---|
| Unit of Quantity | kg |
| General Rate of Duty (Column 1 - General) | Free |
| Special Rate of Duty (Column 1 - Special) | N/A |
| Column 2 Rate of Duty | Free |
| Quota Quantity | N/A |
| Additional Duties | N/A |
Overview
This HTS category, 3002.14.00.10, specifically covers immunological products that contain monoclonal antibodies. Monoclonal antibodies are highly specific proteins produced by identical immune cells that have been cloned. These products are intended for therapeutic, prophylactic, or diagnostic purposes. The key defining characteristic for this classification is the presence and function of monoclonal antibodies, which are distinct from other types of antibodies or broader immunological preparations.
Within its sibling category, 3002.14.00.90, "Other" immunological products are classified. This distinction is crucial: while both categories fall under the broader umbrella of "Antisera, other blood fractions and immunological products," 3002.14.00.10 is reserved for those products where monoclonal antibodies are the principal active component. This implies that products classified under 3002.14.00.90 would not primarily rely on monoclonal antibodies, but rather on other types of immunological agents or mixed formulations not specifically defined by monoclonal antibody content.
As this node is a leaf node, there are no further subcategories. Classification into 3002.14.00.10 is final based on the presence of monoclonal antibodies and their intended application. Practical classification will depend on product documentation, scientific literature identifying the active components, and the stated intended use of the product, distinguishing it from polyclonal antibodies or general immune globulins found in sibling categories.